Peer-assisted injection as a harm reduction measure in a supervised consumption service: a qualitative study of client experiences
Tóm tắt
Peer assistance is an emerging area of study in injection drug use. When Canada’s first supervised consumption site (SCS) opened in 2003 in Vancouver, Canada, clients were prohibited from injecting their peers; only recently has this practise been introduced as a harm reduction measure at these sites. In 2018, Health Canada granted federal exemption to allow peer-assisted injection at certain SCS sites, under the Controlled Drugs and Substances Act. Literature pertaining to peer-assisted injection addresses several topics: interpersonal relationships between the injection provider and recipient; the role of pragmatism; trust and expertise; and gender relations. In this qualitative study, participants (n = 16) were recruited to be interviewed about their experiences in a peer-assisted injection program (PAIP) at one SCS regulated by Health Canada. Interview data were transcribed and thematically analyzed. Quantitative administrative data were used to provide context and to describe the study population, comprised of people in the PAIP (n = 248). PAIP clients made up 17.4% of all SCS clients. PAIP clients were more likely to be female and Indigenous. Injection providers expressed being moved by compassion to help others inject. While their desire to assist was pragmatic, they felt a significant burden of responsibility for the outcomes. Other prominent factors related to the injection provider-recipient relationship were social connection, trust, safety, social capital, and reciprocity. Participants also made suggestions for improving the PAIP which included adding more inhalation rooms so that if someone was unable to inject they could smoke in a safe place instead. Additionally, being required by law to divide drugs outside of the SCS, prior to preparing and using in the site, created unsafe conditions for clients. Regular use of the SCS, and access to its resources, enabled participants to lower their risk through smoking and to practice lower-risk injections. At the federal level, there is considerable room to advocate for allowing clients to divide drugs safely within the SCS, and to increase capacity for safer alternatives such as inhalation.
Tài liệu tham khảo
Brothers S. A good “doctor” is hard to find: assessing uncredentialed expertise in assisted injection. Soc Sci Med. 2019;237:112446.
Wood E, Spittal PM, Kerr T, Small W, Tyndall MW, O’Shaughnessy MV, et al. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health. 2003;94(5):355–9.
McElrath K, Harris J. Peer injecting: implications for injecting order and blood-borne viruses among men and women who inject heroin. J Subst Use. 2013;18(1):31–45.
Pearshouse R, Elliott R. A helping hand: legal issues related to assisted injection at supervised injection facilities. Toronto: Canadian HIV/AIDS Legal Network; 2007.
Gagnon M. It’s time to allow assisted injection in supervised injection sites. Can Med Assoc J. 2017;189(34):E1083–4.
Lamb S, Kral AH, Dominguez-Gonzalez K, Wenger LD, Bluthenthal RN. Peer-to-peer injection: demographic, drug use, and injection-related risk factors. Int J Drug Policy. 2018;61:44–51.
McNeil R, Small W. “Safer environment interventions”: a qualitative synthesis of the experiences and perceptions of people who inject drugs. Soc Sci Med. 2014;106:151–8.
Kolla G, Kenny KS, Bannerman M, Boyce N, Chapman L, Dodd Z, et al. Help me fix: the provision of injection assistance at an unsanctioned overdose prevention site in Toronto, Canada. Int J Drug Policy. 2020;76:102617.
Jozaghi E. Exploring the role of an unsanctioned, supervised peer driven injection facility in reducing HIV and hepatitis C infections in people that require assistance during injection. Health Just. 2015;3(1):16.
McNeil R, Small W, Lampkin H, Shannon K, Kerr T. “People knew they could come here to get help”: An ethnographic study of assisted injection practices at a peer-run ‘unsanctioned’ supervised drug consumption room in a Canadian setting. AIDS Behav. 2014;18(3):473–85.
Kerr T, Oleson M, Tyndall MW, Montaner J, Wood E. A description of a peer-run supervised injection site for injection drug users. J Urban Health. 2005;82(2):267–75.
Wright NM, Tompkins CN, Sheard L. Is peer injecting a form of intimate partner abuse? A qualitative study of the experiences of women drug users. Health Soc Care Community. 2007;15(5):417–25.
McNeil R, Shannon K, Shaver L, Kerr T, Small W. Negotiating place and gendered violence in Canada’s largest open drug scene. Int J Drug Policy. 2014;25(3):608–15.
Fast D, Small W, Wood E, Kerr T. The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility. Harm Reduct J. 2008;5:32.
Wood RA, Wood E, Lai C, Tyndall MW, Montaner JS, Kerr T. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver’s supervised injection facility. Int J Drug Policy. 2008;19(3):183–8.
Small W, Wood E, Tobin D, Rikley J, Lapushinsky D, Kerr T. The Injection Support Team: a peer-driven program to address unsafe injecting in a Canadian setting. Subst Use Misuse. 2012;47(5):491–501.
Wilkins L, Bissell P, Meier PS. Risky injecting practices associated with snowballing: a qualitative study. Drug Alcohol Rev. 2010;29(3):256–62.
Callon C, Charles G, Alexander R, Small W, Kerr T. “On the same level”: facilitators’ experiences running a drug user-led safer injecting education campaign. Harm Reduct J. 2013;10:4.
Dechman MK. Peer helpers’ struggles to care for “others” who inject drugs. Int J Drug Policy. 2015;26(5):492–500.
Kral AH, Bluthenthal RN, Erringer EA, Lorvick J, Edlin BR. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction. 1999;94(5):675–83.
Mitra S, Rachlis B, Scheim A, Bardwell G, Rourke SB, Kerr T. Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City. Harm Reduct J. 2017;14(1):46.
Stengel CM, Mane F, Guise A, Pouye M, Sigrist M, Rhodes T. “They accept me, because I was one of them”: formative qualitative research supporting the feasibility of peer-led outreach for people who use drugs in Dakar, Senegal. . Harm Reduct J. 2018;15:9.
Treloar C, Rance J, Laybutt B, Crawford S. Structural constraints on the training of peer educators in hepatitis C prevention. Health Educ Res. 2012;27(2):248–57.
nea360 Limited. Record | Monitor | Analyse Lancashire, UK: Author; 2020. https://neo360.co/.
Clarke V, Braun V. Thematic analysis. In: Michalos AC, editor. Encyclopedia of quality of life and well-being research. New York: Springer; 2014.
Valencia J, Alvaro-Meca A, Troya J, Gutiérrez J, Ramón C, Rodríguez A, et al. Gender-based vulnerability in women who inject drugs in a harm reduction setting. PLoS ONE. 2020;15(3):e0230886.
Boyd J, Collins AB, Mayer S, Maher L, Kerr T, McNeil R. Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada. Addiction. 2018.
Gjersing L, Bretteville-Jensen AL. Patterns of substance use and mortality risk in a cohort of ‘hard-to-reach’ polysubstance users. Addiction. 2018;113(4):729–39.
Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy. 2009;20(3):193–201.
Kennedy MC, Hayashi K, Milloy MJ, Boyd J, Wood E, Kerr T. Supervised injection facility use and exposure to violence among a cohort of people who inject drugs: a gender-based analysis. Int J Drug Policy. 2020;78:102692.
Bourgois P, Prince B, Moss A. The everyday violence of hepatitis C among young women who inject drugs in San Francisco. Human Organ. 2004;63(3):253–64.
Government of Canada. Controlled drugs and substances act. Ottawa: Author; 2020.
Callon C. Evaluation of a drug user-led safer injecting education campaign. Vancouver: University of British Columbia; 2005.